Your browser doesn't support javascript.
loading
High concentrations of triglycerides are associated with diabetic kidney disease in new-onset type 2 diabetes in China: Findings from the China Cardiometabolic Disease and Cancer Cohort (4C) Study.
Gong, Lei; Wang, Chuan; Ning, Guang; Wang, Weiqing; Chen, Gang; Wan, Qin; Qin, Guijun; Yan, Li; Wang, Guixia; Qin, Yingfen; Luo, Zuojie; Tang, Xulei; Huo, Yanan; Hu, Ruying; Ye, Zhen; Shi, Lixin; Gao, Zhengnan; Su, Qing; Mu, Yiming; Zhao, Jiajun; Chen, Lulu; Zeng, Tianshu; Yu, Xuefeng; Li, Qiang; Shen, Feixia; Zhang, Yinfei; Wang, Youmin; Deng, Huacong; Liu, Chao; Wu, Shengli; Yang, Tao; Bi, Yufang; Lu, Jieli; Li, Mian; Xu, Yu; Xu, Min; Wang, Tiange; Zhao, Zhiyun; Hou, Xinguo; Chen, Li.
Afiliación
  • Gong L; Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, China.
  • Wang C; Institute of Endocrine and Metabolic Diseases of Shandong University, Jinan, China.
  • Ning G; Key Laboratory of Endocrine and Metabolic Diseases, Shandong Province Medicine & Health, Jinan, China.
  • Wang W; Jinan Clinical Research Center for Endocrine and Metabolic Diseases, Jinan, China.
  • Chen G; Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, China.
  • Wan Q; Institute of Endocrine and Metabolic Diseases of Shandong University, Jinan, China.
  • Qin G; Key Laboratory of Endocrine and Metabolic Diseases, Shandong Province Medicine & Health, Jinan, China.
  • Yan L; Jinan Clinical Research Center for Endocrine and Metabolic Diseases, Jinan, China.
  • Wang G; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Qin Y; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
  • Luo Z; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Tang X; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
  • Huo Y; Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China.
  • Hu R; The Affiliated Hospital of Luzhou Medical College, Luzhou, China.
  • Ye Z; The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Shi L; Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Gao Z; The First Hospital of Jilin University, Changchun, China.
  • Su Q; The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Mu Y; The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Zhao J; The First Hospital of Lanzhou University, Lanzhou, China.
  • Chen L; Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, China.
  • Zeng T; Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
  • Yu X; Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
  • Li Q; Affiliated Hospital of Guiyang Medical College, Guiyang, China.
  • Shen F; Dalian Municipal Central Hospital, Dalian, China.
  • Zhang Y; Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Wang Y; Chinese People's Liberation Army General Hospital, Beijing, China.
  • Deng H; Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
  • Liu C; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wu S; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Yang T; Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Bi Y; The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Lu J; The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Li M; Central Hospital of Shanghai Jiading District, Shanghai, China.
  • Xu Y; The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Xu M; The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Wang T; Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, China.
  • Zhao Z; Karamay Municipal People's Hospital, Xinjiang, China.
  • Hou X; The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Chen L; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Diabetes Obes Metab ; 23(11): 2551-2560, 2021 11.
Article en En | MEDLINE | ID: mdl-34322974
ABSTRACT

AIMS:

The aims of this study were to evaluate the associations of metabolic abnormalities with incident diabetic kidney disease (DKD) and to explore whether dyslipidaemia, particularly high fasting triglyceride (TG), was associated with the development of DKD.

METHODS:

In total, 11 142 patients with new-onset type 2 diabetes with baseline estimated glomerular filtration rates (eGFR) ≥60 mL/min/1.73 m2 were followed up during 2011-2016. Incident DKD was defined as eGFR <60 mL/min/1.73 m2 at follow-up. Multiple logistic regression analysis was conducted to explore the relationship of metabolic abnormalities at baseline and at follow-up with risks of DKD. High TG was defined by TG ≥1.70 mmol/L. Low high-density lipoprotein cholesterol (HDL-c) was defined by HDL-c <1.0 mmol/L for men or <1.3 mmol/L for women.

RESULTS:

Participants who developed DKD had higher levels of waist circumference and systolic blood pressure, and lower levels of HDL-c at both baseline and follow-up visits. The DKD group also had higher levels of post-load plasma glucose and TG at follow-up. Multivariate logistic regression analysis revealed that both high TG at baseline [odds ratio (OR) = 1.37, p = .012) and high TG at follow-up (OR = 1.71, p < .001) were significantly associated with increased risks of DKD. Patients with high TG levels at both baseline and follow-up had higher risk of DKD compared with constantly normal TG (OR = 1.65, p < .001) after adjustment for covariates.

CONCLUSIONS:

In a large population of patients with new-onset type 2 diabetes, a high TG level was an independent risk factor for the development of DKD. Tight TG control might delay the occurrence of DKD.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Neoplasias Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Neoplasias Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2021 Tipo del documento: Article País de afiliación: China